A Nonerythropoietic Peptide that Mimics the 3D Structure of Erythropoietin Reduces Organ Injury/Dysfunction and Inflammation in Experimental Hemorrhagic Shock
Nimesh S. A. Patel(William Harvey Research Institute), Christoph Thiemermann(Queen Mary University of London), Michael Brines(Northwell Health), W.S. Fred Wong(Hong Kong Polytechnic University), Roberto Fantozzi(University of Turin), Elisa Benetti(University of Padua), Kiran K. Nandra(Queen Mary University of London), Massimo Collino(Neuroscience Institute), Fera Y. Goh(National University of Singapore), Amar Kapoor(Queen Mary University of London), Anthony Cerami(Araim Pharmaceuticals (United States))
Cited by 35
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Mesenchymal Stromal Cells: Current Understanding and Clinical Status
|Stem Cells|2009|921